Business Context and Reporting Period
Company: Materialise NV
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter 2026 (Three months ended March 31, 2026)
Filing Date: May 7, 2026
Business Overview: Materialise provides software solutions and 3D printing services across healthcare, automotive, aerospace, and consumer goods sectors. The company operates through three segments: Materialise Medical, Materialise Software, and Materialise Manufacturing.
Key Financial Metrics
| Metric | Q1 2026 (kEUR) | Q1 2025 (kEUR) |
|---|---|---|
| Total Revenue | 66,276 | 66,379 |
| Gross Profit | 37,894 | 36,724 |
| Gross Margin | 57.2% | 55.3% |
| Operating Profit | 2,090 | 574 |
| Net Profit | 1,820 | (535) |
| Adjusted EBITDA | 8,049 | 6,147 |
| Adjusted EBIT Margin | 3.7% | 1.0% |
| Cash and Cash Equivalents | 132,952 | 133,918 (Dec 31, 2025) |
| Gross Debt | 60,126 | 63,113 (Dec 31, 2025) |
| Net Cash Position | 72,826 | 70,805 (Dec 31, 2025) |
| Operating Cash Flow | 6,914 | 9,713 |
| Free Cash Flow | Positive | N/A |
Material Changes vs. Prior Period
- Revenue Stability: Total revenue remained flat at 66,276 kEUR compared to 66,379 kEUR in Q1 2025. This stability masked divergent segment performance:
- Medical: Increased 6.7% to 33,165 kEUR.
- Software: Decreased 1.4% to 9,641 kEUR.
- Manufacturing: Decreased 8.1% to 23,470 kEUR.
- Profitability Improvement: The company turned a net loss of 535 kEUR in Q1 2025 into a net profit of 1,820 kEUR in Q1 2026. This was driven by a 3.2% increase in gross profit and a significant improvement in the net financial result (from a loss of 875 kEUR to income of 392 kEUR).
- Expense Management: Aggregate R&D, Sales & Marketing, and G&A expenses remained stable at 36,713 kEUR.
- Segment Adjusted EBITDA:
- Medical: Increased 2.1% to 9,235 kEUR (margin 27.8%).
- Software: Increased 87.4% to 1,123 kEUR (margin 11.6%).
- Manufacturing: Improved from a loss of 377 kEUR to a profit of 281 kEUR (margin 1.2%).
- Balance Sheet: Gross debt decreased by 2,987 kEUR to 60,126 kEUR. Net cash position improved to 72,826 kEUR.
Outlook, Risks, and Unusual Items
- Eyewear Business Transfer: Subsequent to March 31, 2026, Materialise agreed to transfer its eyewear business to the management team, retaining a minority stake. The company expects to recognize impairment charges related to this transaction in the second quarter of 2026.
- Share Buyback: The company repurchased 511,513 shares for 2,308 kEUR (2,722 kUSD) under its existing program.
- Non-IFRS Measures: Management utilizes Adjusted EBITDA and Adjusted EBIT to evaluate performance, excluding share-based compensation, restructuring costs, and impairments.
- Exchange Rates: Financial results are presented in EUR. USD translations use a rate of 1.1498 (March 31, 2026).
Investor Verification Checklist
- Impairment Timing: Verify the magnitude and timing of expected impairment charges related to the eyewear business transfer in Q2 2026.
- Manufacturing Segment Sustainability: Assess whether the turnaround in the Manufacturing segment (from negative to positive Adjusted EBITDA) is sustainable given the 8.1% revenue decline.
- Debt Covenants: Confirm compliance with financial covenants given the use of Adjusted EBITDA as a monitoring metric.
- Working Capital Trends: Review the 1,693 kEUR negative working capital adjustment in operating cash flow, driven primarily by a 1,933 kEUR increase in inventories.
- Minority Stake Valuation: Evaluate the strategic and financial implications of retaining a minority stake in the newly formed eyewear company.